Cardio Diagnostics Holdings Inc
CDIO3.520USD
+0.160+4.76%
收盤 12/24, 13:00（美東）報價延遲15分鐘
6.22M總市值
虧損本益比TTM
關於 Cardio Diagnostics Holdings Inc 公司
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Cardio Diagnostics Holdings Inc簡介
公司代碼CDIO
公司名稱Cardio Diagnostics Holdings Inc
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)
員工數量13
證券類型Ordinary Share
年結日Nov 23
公司地址311 W. Superior Street
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60645
電話18552269991
網址
公司代碼CDIO
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)
Cardio Diagnostics Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
其他
89.74%
持股股東
持股股東
佔比
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
其他
89.74%
股東類型
持股股東
佔比
Investment Advisor
4.35%
Individual Investor
3.90%
Corporation
2.90%
Hedge Fund
1.12%
Investment Advisor/Hedge Fund
0.83%
其他
86.91%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
39
115.09K
6.22%
--
2025Q3
41
115.09K
6.70%
+30.25K
2025Q2
39
84.84K
5.90%
+274.00
2025Q1
35
84.57K
5.41%
-9.47K
2024Q4
39
85.72K
5.08%
+29.79K
2024Q3
59
55.93K
19.52%
-4.45K
2024Q2
61
60.37K
27.33%
+6.29K
2024Q1
58
54.08K
29.21%
-151.37K
2023Q4
58
55.21K
23.41%
+40.18K
2023Q3
53
15.03K
36.07%
+2.55K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Dogan (Meeshanthini)
55.18K
3.13%
--
--
Aug 25, 2025
Bd Holding, Inc
52.88K
3%
--
--
Aug 25, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
2.02%
-2.00
-0.01%
Jun 30, 2025
The Vanguard Group, Inc.
12.68K
0.72%
+265.00
+2.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
13.37K
0.76%
+198.00
+1.50%
Jun 30, 2025
Dogan (Timur)
4.28K
0.24%
--
--
Aug 25, 2025
Hosseinion (Warren)
3.87K
0.22%
+1.00
+0.03%
Aug 25, 2025
Philibert (Robert)
3.25K
0.18%
+1.00
+0.03%
Aug 25, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 08, 2025
Merger
30→1
公告日期
類型
比率
May 08, 2025
Merger
30→1
常見問題
Cardio Diagnostics Holdings Inc的前五大股東是誰？
Cardio Diagnostics Holdings Inc的前五大股東如下：
Dogan (Meeshanthini)持有股份：55.18K佔總股份比例：3.13%。
Bd Holding, Inc持有股份：52.88K佔總股份比例：3.00%。
BlackRock Institutional Trust Company, N.A.持有股份：35.57K佔總股份比例：2.02%。
The Vanguard Group, Inc.持有股份：12.68K佔總股份比例：0.72%。
Geode Capital Management, L.L.C.持有股份：13.37K佔總股份比例：0.76%。
Dogan (Meeshanthini)持有股份：55.18K佔總股份比例：3.13%。
Bd Holding, Inc持有股份：52.88K佔總股份比例：3.00%。
BlackRock Institutional Trust Company, N.A.持有股份：35.57K佔總股份比例：2.02%。
The Vanguard Group, Inc.持有股份：12.68K佔總股份比例：0.72%。
Geode Capital Management, L.L.C.持有股份：13.37K佔總股份比例：0.76%。
Cardio Diagnostics Holdings Inc的前三大股東類型是什麼？
Cardio Diagnostics Holdings Inc 的前三大股東類型分別是：
Dogan (Meeshanthini)
Bd Holding, Inc
BlackRock Institutional Trust Company, N.A.
Dogan (Meeshanthini)
Bd Holding, Inc
BlackRock Institutional Trust Company, N.A.
有多少機構持有Cardio Diagnostics Holdings Inc(CDIO)的股份？
截至2025Q4，共有39家機構持有Cardio Diagnostics Holdings Inc的股份，合計持有的股份價值約為115.09K，占公司總股份的6.22% 。與2025Q3相比，機構持股有所增加，增幅為-0.48%。
哪個業務部門對Cardio Diagnostics Holdings Inc的收入貢獻最大？
在--，--業務部門對Cardio Diagnostics Holdings Inc的收入貢獻最大，創收--，占總收入的--% 。
